See other bills
under the
same topic
PRINTER'S NO. 338
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No.
74
Session of
2021
INTRODUCED BY MARTIN, K. WARD, MENSCH, AUMENT, ARGALL, STEFANO,
REGAN, COSTA, BOSCOLA, FONTANA AND SANTARSIERO,
MARCH 10, 2021
REFERRED TO FINANCE, MARCH 10, 2021
AN ACT
Amending the act of March 4, 1971 (P.L.6, No.2), entitled "An
act relating to tax reform and State taxation by codifying
and enumerating certain subjects of taxation and imposing
taxes thereon; providing procedures for the payment,
collection, administration and enforcement thereof; providing
for tax credits in certain cases; conferring powers and
imposing duties upon the Department of Revenue, certain
employers, fiduciaries, individuals, persons, corporations
and other entities; prescribing crimes, offenses and
penalties," providing for pediatric cancer research tax
credit.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. The act of March 4, 1971 (P.L.6, No.2), known as
the Tax Reform Code of 1971, is amended by adding an article to
read:
ARTICLE XVII-M
PEDIATRIC CANCER RESEARCH TAX CREDIT
Section 1701-M. Scope of article.
This article relates to pediatric cancer research tax
credits.
Section 1702-M. Definitions.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
The following words and phrases when used in this article
shall have the meanings given to them in this section unless the
context clearly indicates otherwise:
"Business firm." An entity authorized to do business in this
Commonwealth and subject to taxes imposed under Article III, IV,
VII, VIII, IX or XV. The term includes a pass-through entity.
"Contribution." A donation of cash to a pediatric cancer
research institution .
"Department." The Department of Revenue of the Commonwealth.
"Pass-through entity." A partnership as defined under
section 301(n.0) or a Pennsylvania S corporation as defined
under section 301(n.1).
"Pediatric cancer research institution." A hospital located
within this Commonwealth which is equipped and actively
conducting pediatric cancer research designated by the Secretary
of Health to be eligible to receive contributions under this
article.
"Tax credit." A tax credit for pediatric cancer research
authorized under this article.
Section 1703-M. Pediatric cancer research tax credit.
A tax credit shall be granted to a business firm that meets
the requirements under this article for the purposes of funding
pediatric cancer research in this Commonwealth.
Section 1704-M. Restriction on use of contributions.
The contributions received by a pediatric cancer research
institution from a business firm claiming a tax credit must be
used exclusively for pediatric cancer research.
Section 1705-M. Availability of tax credits.
(a) Application.--A business firm may submit an application
to the department for a tax credit. A business firm may receive
20210SB0074PN0338 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
a tax credit if a pediatric cancer research institution receives
a contribution from the business firm as determined by the
department and in accordance with this article.
(b) Tax credit availability.--Tax credits under this section
shall be made available by the department on a first- come,
first-served basis.
(c) Contributions.--A contribution by a business firm to a
pediatric cancer research institution shall be made no later
than 30 days after the business firm receives notice of the
approval of the application under section 1707-M(b).
(d) Application in the alternative.--At the time of
application for a tax credit, the department shall advise a
business firm that the firm may elect that its application for a
tax credit for a contribution to a particular pediatric cancer
research institution will, in the alternative, be deemed an
application received by the department on the same date as the
preferred application, but for a different pediatric cancer
research institution authorized under this article if the
business firm's preferred choice of pediatric cancer research
institution has reached the $2,500,000 limit under section 1709-
M. If a business firm does not receive its preferred choice of
pediatric cancer research institution, the department shall
promptly consider the business firm's application in the
alternative for a different pediatric cancer research
institution authorized under this article.
Section 1706-M. Duties.
(a) Department.--The department shall have the following
duties:
(1) Promulgating regulations necessary to implement this
article.
20210SB0074PN0338 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
(2) Creating and publishing forms upon which business
firms may apply for the tax credit under this article.
(3) Approving or disapproving applications submitted by
business firms and providing notice of the approval or
disapproval to applicants under section 1707-M(b).
(4) Granting tax credit certificates in accordance with
section 1708-M.
(b) Secretary of Health.--On or before December 31 of each
year, the Secretary of Health shall designate hospitals within
this Commonwealth which are equipped and actively conducting
pediatric cancer research to be eligible to receive
contributions under this article for the following taxable year.
Section 1707-M. Procedures.
(a) Deadline for filing applications.--Applications for a
tax credit under this article shall be filed not later than
December 31.
(b) Notice.--
(1) The department shall notify the business firm
regarding the authorization of tax credits and its
determination, including the amount of the credit available.
(2) The department may return an incomplete application
to the business firm or request additional information,
documents or signatures from the business firm.
(c) Appeals.--Appeals from determinations made under
subsection (b) shall be made through the administrative
provisions of this act, applicable to the particular taxes
against which the business firm or its members, shareholders or
partners claim the tax credits.
Section 1708-M. Grant of tax credit certificates.
In accordance with section 1709-M(a), the department shall
20210SB0074PN0338 - 4 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
grant a tax credit certificate to a business firm eligible to
receive a tax credit in accordance with this article. The
certificate may be used against a tax liability owed to the
department by a business firm that provides proof of a
contribution to a pediatric cancer research institution in the
taxable year in which the contribution is made. The business
firm may apply the credit against any tax due under Article III,
IV, VII, VIII, IX or XV, excluding any tax withheld by an
employer under Article III.
Section 1709-M. Amount of tax credits.
(a) General rule.--The total aggregate amount of all tax
credits approved shall not exceed $10,000,000 in a fiscal year.
A tax credit may not be approved in excess of $2,500,000 in a
fiscal year for contributions to any one pediatric cancer
research institution.
(b) Activities.--No tax credit shall be approved for
activities that are part of a business firm's normal course of
business.
Section 1710-M. Carryover and carryback.
(a) General rule.--If a business firm does not use all or
any portion of a tax credit for the taxable year in which the
tax credit is first approved, the excess may be carried over to
succeeding taxable years and used as a credit against the
qualified tax liability of the business firm for those taxable
years. Each time the tax credit is carried over to a succeeding
taxable year, it shall be reduced by the amount that was used as
a credit during the immediately preceding taxable year. The tax
credit provided by this article may be carried over and applied
to succeeding taxable years for no more than three taxable years
following the first taxable year for which the taxpayer was
20210SB0074PN0338 - 5 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
entitled to claim the credit.
(b) Application.--A tax credit approved by the department in
a taxable year first shall be applied against the business
firm's qualified tax liability for the current taxable year as
of the date on which the tax credit was approved before the tax
credit can be applied against a tax liability under subsection
(a).
(c) No carryback or refund.--A business firm is not entitled
to carry back or obtain a refund of all or any portion of an
unused tax credit granted to the business firm under this
article.
Section 1711-M. Pass-through entity.
(a) General rule.--If a business firm which is a pass-
through entity has any unused tax credits under section 1710-M,
the pass-through entity may elect in writing, according to
procedures established by the department, to transfer all or a
portion of the tax credits to shareholders, members or partners
in proportion to the share of the entity's distributive income
to which each shareholder, member or partner is entitled.
(b) Limitation.--A pass-through entity and a shareholder,
member or partner of a pass-through entity may not claim the tax
credit under subsection (a) for the same contribution.
(c) Claim.--A shareholder, member or partner of a pass-
through entity to whom a tax credit is transferred under
subsection (a) shall immediately claim the tax credit in the
taxable year in which the transfer is made. The shareholder,
member or partner may not carry forward, carry back, obtain a
refund of or sell or assign the tax credit.
(d) Application.--An individual shareholder, member or
partner may apply a tax credit distributed under this section to
20210SB0074PN0338 - 6 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
income taxable under Article III to the shareholder, member or
partner, to the spouse of the shareholder, member or partner or
to both, if both the shareholder, member or partner and the
spouse report income on a joint personal income tax return.
Section 1712-M. Sale or assignment.
(a) Authorization.--Upon approval by the department, a
business firm may sell or assign, in whole or in part, a tax
credit granted to the business firm under this article.
(b) Application.--The following shall apply:
(1) To sell or assign a tax credit, a business firm must
file an application for the sale or assignment of the tax
credit with the department. The application must be on a form
required by the department.
(2) The department shall approve a sale or assignment if
the purchaser or assignee has:
(i) filed all required State tax reports and returns
for all applicable taxable years; and
(ii) paid any balance of State tax due as determined
by assessment or determination by the department and not
under timely appeal.
Section 1713-M. Purchasers and assignees.
(a) Claim.--The purchaser or assignee of all or a portion of
a tax credit under section 1712-M shall immediately claim the
credit in the taxable year in which the purchase or assignment
is made.
(b) Amount.--The amount of the tax credit that a purchaser
or assignee may use against any one qualified tax liability may
not exceed 75% of the qualified tax liability for the taxable
year.
(c) Use.--The purchaser or assignee may not carry forward,
20210SB0074PN0338 - 7 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
carry back or obtain a refund of or sell or assign the tax
credit.
Section 1714-M. Administration.
(a) Audits and assessments.--The department has the
following powers:
(1) To audit a business firm claiming a tax credit to
ascertain the validity of the amount claimed.
(2) To issue an assessment against a business firm for
an improperly issued tax credit. The procedures, collection,
enforcement and appeals of any assessment made under this
section shall be governed by Article IV.
(b) Guidelines.--The department shall develop written
guidelines for the implementation of this article.
Section 1715-M. Annual report to General Assembly.
By October 1, 2022, and October 1 of each year thereafter,
the department shall submit a report on the tax credit provided
by this article to the chairperson and minority chairperson of
the Appropriations Committee of the Senate, the chairperson and
minority chairperson of the Finance Committee of the Senate, the
chairperson and minority chairperson of the Appropriations
Committee of the House of Representatives and the chairperson
and minority chairperson of the Finance Committee of the House
of Representatives. The report must include:
(1) the names of the business firms utilizing the tax
credit as of the date of the report and the amount of tax
credits approved for, utilized by or sold or assigned by a
business firm during the preceding fiscal year; and
(2) the amount of contributions received by each of the
four pediatric cancer research institutes during the
preceding fiscal year.
20210SB0074PN0338 - 8 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Section 1716-M . Limitation.
A business firm may not apply for a tax credit after the 10th
fiscal year after the effective date of this section.
Section 1717-M . Applicability.
The tax credit established under this article shall apply to
taxable years beginning after December 31, 2021.
Section 2. This act shall take effect in 60 days.
20210SB0074PN0338 - 9 -
1
2
3
4
5
6
7